OPKO Health Inc (OPK)
1.44
-0.04
(-2.70%)
USD |
NASDAQ |
Nov 05, 11:38
OPKO Health Enterprise Value: 1.185B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.185B |
| November 01, 2024 | 1.206B |
| October 31, 2024 | 1.206B |
| October 30, 2024 | 1.213B |
| October 29, 2024 | 1.269B |
| October 28, 2024 | 1.199B |
| October 25, 2024 | 1.144B |
| October 24, 2024 | 1.130B |
| October 23, 2024 | 1.172B |
| October 22, 2024 | 1.172B |
| October 21, 2024 | 1.165B |
| October 18, 2024 | 1.179B |
| October 17, 2024 | 1.172B |
| October 16, 2024 | 1.192B |
| October 15, 2024 | 1.179B |
| October 14, 2024 | 1.179B |
| October 11, 2024 | 1.172B |
| October 10, 2024 | 1.179B |
| October 09, 2024 | 1.199B |
| October 08, 2024 | 1.179B |
| October 07, 2024 | 1.165B |
| October 04, 2024 | 1.192B |
| October 03, 2024 | 1.206B |
| October 02, 2024 | 1.213B |
| October 01, 2024 | 1.192B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.192B |
| September 27, 2024 | 1.213B |
| September 26, 2024 | 1.192B |
| September 25, 2024 | 1.185B |
| September 24, 2024 | 1.185B |
| September 23, 2024 | 1.199B |
| September 20, 2024 | 1.185B |
| September 19, 2024 | 1.262B |
| September 18, 2024 | 1.282B |
| September 17, 2024 | 1.310B |
| September 16, 2024 | 1.296B |
| September 13, 2024 | 1.248B |
| September 12, 2024 | 1.234B |
| September 11, 2024 | 1.241B |
| September 10, 2024 | 1.262B |
| September 09, 2024 | 1.241B |
| September 06, 2024 | 1.241B |
| September 05, 2024 | 1.269B |
| September 04, 2024 | 1.282B |
| September 03, 2024 | 1.282B |
| August 30, 2024 | 1.324B |
| August 29, 2024 | 1.262B |
| August 28, 2024 | 1.303B |
| August 27, 2024 | 1.303B |
| August 26, 2024 | 1.291B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
756.69M
Minimum
Mar 18 2024
4.254B
Maximum
Jul 21 2020
1.906B
Average
1.571B
Median
May 08 2023
Enterprise Value Benchmarks
| Innerscope Hearing Technologies Inc | -- |
| Abbott Laboratories | 211.48B |
| Boston Scientific Corp | 133.49B |
| ICU Medical Inc | 5.504B |
| Outset Medical Inc | 34.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.30M |
| Revenue (Quarterly) | 182.19M |
| Total Expenses (Quarterly) | 243.86M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 28.35% |
| Profit Margin (Quarterly) | -5.66% |
| Earnings Yield | -22.92% |
| Normalized Earnings Yield | -20.48 |